Anti-CD30 chimeric antigen receptor T cell therapy for relapsed/refractory CD30+ lymphoma patients
Anti-CD30 chimeric antigen receptor T cell therapy for relapsed/refractory CD30+ lymphoma patients
About this item
Full title
Anti-CD30 chimeric antigen receptor T cell therapy for relapsed/refractory CD30+ lymphoma patients
Author / Creator
Wang, D. , Zeng, C. , Xu, B. , Xu, J.-H. , Wang, J. , Jiang, L.-J. , Wang, Q.-X. , Li, C.-R. , Wang, N. , Huang, L. , Zhang, Y.-C. , Xiao, Y. and Zhou, J.-F.
Publisher
London: Nature Publishing Group UK
Journal title
Blood cancer journal (New York), 2020-01, Vol.10 (1), p.8-8, Article 8
Language
English
Formats
Publication information
Publisher
London: Nature Publishing Group UK
Subjects
More information
Alternative Titles
Full title
Anti-CD30 chimeric antigen receptor T cell therapy for relapsed/refractory CD30+ lymphoma patients
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6978321
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6978321
Other Identifiers
ISSN
2044-5385
E-ISSN
2044-5385
DOI
10.1038/s41408-020-0274-9
